Search

Your search keyword '"Stojkovic, Tanya"' showing total 1,055 results

Search Constraints

Start Over You searched for: Author "Stojkovic, Tanya" Remove constraint Author: "Stojkovic, Tanya"
1,055 results on '"Stojkovic, Tanya"'

Search Results

2. Phenotype variability and natural history of X-linked myopathy with excessive autophagy

3. A CCG expansion in ABCD3 causes oculopharyngodistal myopathy in individuals of European ancestry

4. Author Correction: A CCG expansion in ABCD3 causes oculopharyngodistal myopathy in individuals of European ancestry

5. Multidisciplinary team meetings in treatment of spinal muscular atrophy adult patients: a real-life observatory for innovative treatments

6. Provisional practice recommendation for the management of myopathy in VCP-associated multisystem proteinopathy.

7. Genetic characterization of non-5q proximal spinal muscular atrophy in a French cohort: the place of whole exome sequencing

8. Motor neuron pathology in CANVAS due to RFC1 expansions

9. Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP-mediated disease reveals characteristic features useful for diagnosis

10. Correction to: Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP‑mediated disease reveals characteristic features useful for diagnosis

11. Genotype-phenotype correlations in valosin-containing protein disease: a retrospective muticentre study.

12. Defining the landscape of TIA1 and SQSTM1 digenic myopathy

13. Cardiac and pulmonary findings in dysferlinopathy: A 3‐year, longitudinal study

15. Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

16. Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

17. A Solve-RD ClinVar-based reanalysis of 1522 index cases from ERN-ITHACA reveals common pitfalls and misinterpretations in exome sequencing

18. Expanding the muscle imaging spectrum in dysferlinopathy: description of an outlier population from the classical MRI pattern

19. Myostatin and follistatin as monitoring and prognostic biomarkers in dysferlinopathy

20. Neuro-Psychological Outcome of ICU-Admitted COVID-19 Patients Presenting With CNS Complications

21. Expanding the importance of HMERF titinopathy: new mutations and clinical aspects

23. Cardiac Outcomes in Adults With Mitochondrial Diseases

24. Diagnostic interest of whole-body MRI in early- and late-onset LAMA2 muscular dystrophies: a large international cohort

27. Heterozygous frameshift variants in HNRNPA2B1 cause early-onset oculopharyngeal muscular dystrophy

28. The Hexokinase 1 5′-UTR Mutation in Charcot–Marie–Tooth 4G Disease Alters Hexokinase 1 Binding to Voltage-Dependent Anion Channel-1 and Leads to Dysfunctional Mitochondrial Calcium Buffering

31. Dystrophies musculaires des ceintures associées aux mutations de TRIM32 : cohorte française et revue de la littérature

33. Miyoshi myopathy and limb girdle muscular dystrophy R2 are the same disease

34. Missense mutations in small muscle protein X-linked (SMPX) cause distal myopathy with protein inclusions

35. Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trial

38. The recurrent deep intronic pseudoexon-inducing variant COL6A1 c.930+189C>T results in a consistently severe phenotype of COL6-related dystrophy: Towards clinical trial readiness for splice-modulating therapy

39. Genomic sequencing highlights the diverse molecular causes of Perrault syndrome: a peroxisomal disorder (PEX6), metabolic disorders (CLPP, GGPS1), and mtDNA maintenance/translation disorders (LARS2, TFAM)

40. European muscle MRI study in limb girdle muscular dystrophy type R1/2A (LGMDR1/LGMD2A)

41. A multicenter cross-sectional French study of the impact of COVID-19 on neuromuscular diseases

42. A previously unreported NARS1 variant causes dominant distal hereditary motor neuropathy in a French family.

43. A study concept of expeditious clinical enrollment for genetic modifier studies in Charcot–Marie–Tooth neuropathy 1A.

44. Serum Neurofilament Light Chain in Replication Factor Complex Subunit 1 CANVAS and Disease Spectrum

45. L’annonce d’une maladie neuromusculaire à un patient adulte : et après ?

46. MFN2-associated lipomatosis: Clinical spectrum and impact on adipose tissue

48. LRSAM1 variants and founder effect in French families with ataxic form of Charcot-Marie-Tooth type 2

50. Prognosis of Right Ventricular Systolic Dysfunction in Patients With Duchenne Muscular Dystrophy

Catalog

Books, media, physical & digital resources